As of 2024-12-11, the EV/EBITDA ratio of LeMaitre Vascular Inc (LMAT) is 36.54. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LMAT's latest enterprise value is 2,164.73 mil USD. LMAT's TTM EBITDA according to its financial statements is 59.25 mil USD. Dividing these 2 quantities gives us the above LMAT EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 18.9x | 18.0x |
| Forward P/E multiples | 20.3x - 21.8x | 20.6x |
| Fair Price | 44.75 - 50.74 | 46.83 |
| Upside | -54.0% - -47.8% | -51.8% |
| Date | EV/EBITDA |
| 2024-12-10 | 37.36 |
| 2024-12-09 | 36.54 |
| 2024-12-06 | 38.01 |
| 2024-12-05 | 38.53 |
| 2024-12-04 | 39.48 |
| 2024-12-03 | 39.49 |
| 2024-12-02 | 39.67 |
| 2024-11-29 | 40.24 |
| 2024-11-27 | 39.79 |
| 2024-11-26 | 39.65 |
| 2024-11-25 | 40.28 |
| 2024-11-22 | 40.61 |
| 2024-11-21 | 39.82 |
| 2024-11-20 | 38.89 |
| 2024-11-19 | 39.01 |
| 2024-11-18 | 38.93 |
| 2024-11-15 | 38.36 |
| 2024-11-14 | 38.17 |
| 2024-11-13 | 38.56 |
| 2024-11-12 | 38.83 |
| 2024-11-11 | 39.68 |
| 2024-11-08 | 39.20 |
| 2024-11-07 | 38.00 |
| 2024-11-06 | 38.24 |
| 2024-11-05 | 37.07 |
| 2024-11-04 | 36.20 |
| 2024-11-01 | 35.65 |
| 2024-10-31 | 33.18 |
| 2024-10-30 | 33.43 |
| 2024-10-29 | 33.95 |
| 2024-10-28 | 32.78 |
| 2024-10-25 | 32.14 |
| 2024-10-24 | 32.50 |
| 2024-10-23 | 32.65 |
| 2024-10-22 | 32.76 |
| 2024-10-21 | 33.27 |
| 2024-10-18 | 33.75 |
| 2024-10-17 | 33.68 |
| 2024-10-16 | 34.37 |
| 2024-10-15 | 34.27 |
| 2024-10-14 | 34.61 |
| 2024-10-11 | 34.02 |
| 2024-10-10 | 33.52 |
| 2024-10-09 | 34.91 |
| 2024-10-08 | 33.94 |
| 2024-10-07 | 33.61 |
| 2024-10-04 | 34.41 |
| 2024-10-03 | 34.08 |
| 2024-10-02 | 34.18 |
| 2024-10-01 | 34.12 |